Kirkland & Ellis advised TA Associates, a leading global growth private equity firm, on the sale of a majority interest in Aldevron to EQT Partners. TA Associates along with founders and management will retain a minority stake in Aldevron. Aldevron is the leading global supplier of GMP, GMP-SourceTM and Research Grade plasmid DNA used in commercial, clinical and research stage gene therapies, as well as proteins, antibodies and mRNA. Financial terms of the transaction were not disclosed. The transaction is expected to close by year-end, subject to customary regulatory approvals.
Read the company press release
The Kirkland team was led by transactional partners Sean Kramer, Shelly Hirschtritt and Jeff Seifman; and tax partners Vincent Thorn and Russell Light; and included debt finance partners Brian Ford and Christopher Kirkham; international trade partner Mario Mancuso and associate Luci Hague; intellectual property partner Dan Lewis; employee benefits partner Melissa Grim; and healthcare partner Dennis Williams.